Patents by Inventor David LAURIN

David LAURIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated strain of pseudomonas as a vaccine for pseudomonas infection
    Patent number: 11045539
    Abstract: The present disclosure is related to a live-attenuated strain of Pseudomonas for its use as a vaccine, and for use in a method for preventive immunizing and for treating Pseudomonas infection, in particular in patients suffering from cystic fibrosis. Preferably, the live-attenuated strain of Pseudomonas is furthermore treated to become ‘killed but metabolically active’.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: June 29, 2021
    Assignees: Universite Grenoble Alpes, Centre Hospitalier Universitaire Grenoble Alpes, Establissement Francais Du Sang
    Inventors: Audrey Le Gouellec, Bertrand Toussaint, Jean-Luc Lenormand, David Laurin, Elodie Meynet
  • ATTENUATED STRAIN OF PSEUDOMONAS AS A VACCINE FOR PSEUDOMONAS INFECTION
    Publication number: 20200023052
    Abstract: The present disclosure is related to a live-attenuated strain of Pseudomonas for its use as a vaccine, and for use in a method for preventive immunizing and for treating Pseudomonas infection, in particular in patients suffering from cystic fibrosis. Preferably, the live-attenuated strain of Pseudomonas is furthermore treated to become ‘killed but metabolically active’.
    Type: Application
    Filed: February 15, 2018
    Publication date: January 23, 2020
    Applicants: UNIVERSITÉ GRENOBLE ALPES, CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE ALPES, ETABLISSEMENT FRANÇAIS DU SANG
    Inventors: Audrey LE GOUELLEC, Bertrand TOUSSAINT, Jean-Luc LENORMAND, David LAURIN, Elodie MAYNET